🔎 Trials Near Me

Hjem › Pankreaskreft › Illinois

Kliniske studier for Pankreaskreft i Illinois

31 studier for Pankreaskreft søker deltakere på steder i Illinois.

Byer i Illinois

Offisiell studietekst (engelsk)

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, Chicago
RekruttererFase 1/2
Alder 18 til 130 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05417594

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • Illinois Cancer Specialists, Arlington Heights
  • City of Hope, Chicago
  • OSF Medical Center, Peoria
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

  • Northwestern University, Chicago
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05372614

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • University of Chicago Hospital, Chicago
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06465069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • University of Illinois Cancer Center, Chicago
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

  • Northwestern Medicine Chicago Proton Center, Warrenville
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT02598349

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

  • University of Chicago Medical Center, Chicago
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07621718

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • City of Hope Cancer Center-Chicago, Zion
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07277413

Pancreatic Cancer Detection Consortium

  • OSF HealthCare, Peoria
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06388967

DESTINY-PANTUMOUR04

  • Research Site, Decatur
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Cancer Care Specialists of Illinois, Decatur
  • Decatur Memorial Hospital, Decatur
  • Hope and Healing Clinical Research LLC, Hinsdale
  • og 2 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06989437

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US079, Chicago
  • Investigative Site US030, Evanston
  • Investigative Site US005, Naperville
  • og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07522073

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

  • OSF Saint Francis Medical Center, Peoria
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06271291

CREO - Microwave Ablation Feasibility Study

  • Rush University Medical Center, Chicago
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07817147

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • Advocate Outpatient Center - Aurora, Aurora
  • Advocate Good Shepherd Hospital, Barrington
  • Carle BroMenn Outpatient Center, Bloomington
  • og 52 flere
RekruttererObservasjonsstudie
Alder 50 til 75 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT04239573

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

  • Memorial Hospital East, Shiloh
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT05687123

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

  • Northwestern University, Chicago
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT07594626

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Rush-Copley Medical Center, Aurora
  • Advocate Outpatient Center - Aurora, Aurora
  • Illinois CancerCare-Bloomington, Bloomington
  • og 45 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT06958328

Pancreatic Cancer Early Detection Consortium

  • Illinois CancerCare, Bloomington
  • University of Chicago Medicine, Chicago
  • NorthShore University HealthSystem, Evanston
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 90 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT04970056

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

  • Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
  • Hope and Healing Cancer Services, Hinsdale
  • Orchard Healthcare Research, Skokie
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT06937177

Integrated Cancer Repository for Cancer Research

  • Rush-Copley Cancer Care Center, Aurora
  • Rush-Copley Healthcare Center, Yorkville
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

  • University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
  • University of Chicago Medical Center /ID# 276271, Chicago
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT05005403

Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy

  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb
  • Northwestern Medicine Cancer Center Delnor, Geneva
  • Northwestern Medicine Cancer Center Warrenville, Warrenville
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 18. jun. 2026 · NCT04616131

Lidocaine Infusion in Pancreatic Cancer

  • University of Illnois at Chicago, Chicago
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jun. 2026 · NCT04048278

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

  • Illinois CancerCare-Bloomington, Bloomington
  • Illinois CancerCare-Canton, Canton
  • Memorial Hospital of Carbondale, Carbondale
  • og 29 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT06998940

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

  • Northwestern University, Chicago
  • University of Illinois, Chicago
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 31. mar. 2026 · NCT06807437

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University-Telemedicine, Champaign
  • Ohio State University-Telemedicine, Chicago
  • Ohio State University Telemedicine, Quincy
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT06906562

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  • OSF Saint Anthony's Health Center, Alton
  • Advocate Good Shepherd Hospital, Barrington
  • Illinois CancerCare-Bloomington, Bloomington
  • og 40 flere
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 9. jan. 2026 · NCT06073431

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chicago
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

  • Advocate Christ Medical Center, Oak Lawn
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. jun. 2025 · NCT02843945

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

  • Northwestern University, Chicago
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 10. mar. 2023 · NCT05733000

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.